title: Complete remission in a patient with angiosarcoma by the combination of OK-432, rhIL-2, and radiotherapy.
authors.forename: Tomoko
authors.initials: T
authors.lastname: Inaba
authors.forename: Kei-Ichi
authors.initials: K
authors.lastname: Yamanaka
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Asahi
authors.forename: Youichi
authors.initials: Y
authors.lastname: Omoto
authors.forename: Kenichi
authors.initials: K
authors.lastname: Isoda
authors.forename: Daniel
authors.initials: D
authors.lastname: Hurwitz
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Kupper
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Mizutani
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D006394:Hemangiosarcoma / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D010844:Picibanil / Q000008:administration & dosage*; D011994:Recombinant Proteins / Q000008:administration & dosage; D012074:Remission Induction; D012878:Skin Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2; D011994:Recombinant Proteins; D010844:Picibanil